| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 133, 173-192, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
MA Nalesnik, R Jaffe, TE Starzl, AJ Demetris, K Porter, JA Burnham, L Makowka, M Ho and J Locker
Department of Pathology, Veteran's Administration Hospital, Pittsburgh, Pennsylvania.
Posttransplant lymphoproliferative disorders (PTLDs) were diagnosed in 43 patients from the Pittsburgh-Denver series between June 1980 and March 1987. This constitutes a detection rate of 1.7%. Major categories of clinical presentation included a mononucleosislike syndrome, gastrointestinal/abdominal disease, and solid organ disease. The median time of onset in patients initially immunosuppressed with cyclosporine- A (CsA)-containing regimens was 4.4 months after transplant, regardless of tumor clonality. A strong association of PTLD with Epstein-Barr virus (EBV) was observed. A histologic spectrum of lesions from polymorphic to monomorphic was observed. Whereas polymorphic lesions could be either clonal or nonclonal, monomorphic lesions appeared to be clonal in composition. The presence of large atypical cells (atypical immunoblasts) or necrosis did not appreciably worsen the prognosis. Twelve patients had clonal, 13 had nonclonal, and five had both clonal and nonclonal tumors. Clonality was indeterminate in 13 cases. Most patients were treated with a regimen based on reduced immunosuppression and supportive surgery. Almost all nonclonal and about half of the clonal lesions respond to this conservative therapy, indicating that it is an appropriate first line of treatment. This behavior suggests that a spectrum of lesions ranging from infectious mononucleosis to malignant lymphoma constitutes the entity known as PTLD. Some monoclonal tumors can undergo regression, however, apparently in response to host immune control mechanisms. Because of its short latency and strong association with EBV, PTLD is an important model for the study of virus-associated tumor progression in humans.
This article has been cited by other articles:
 |
|
 |
|
  S. Y. Kristinsson, L. R. Goldin, M. Bjorkholm, J. Koshiol, I. Turesson, and O. Landgren Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies Haematologica, November 1, 2009; 94(11): 1581 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Borhani, K. Hosseinzadeh, O. Almusa, A. Furlan, and M. Nalesnik Imaging of Posttransplantation Lymphoproliferative Disorder after Solid Organ Transplantation1 RadioGraphics, July 1, 2009; 29(4): 981 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, Q. Huang, C. W. Zuppan, E. H. Rowsell, J. D. Cao, L. M. Weiss, and J. Wang Complete Absence of KSHV/HHV-8 in Posttransplant Lymphoproliferative Disorders: An Immunohistochemical and Molecular Study of 52 Cases Am J Clin Pathol, May 1, 2009; 131(5): 632 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O'Mahony, J. C. Morris, M. Stetler-Stevenson, H. Matthews, M. R. Brown, T. Fleisher, S. Pittaluga, M. Raffeld, P. S. Albert, D. Reitsma, et al. EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies Clin. Cancer Res., April 1, 2009; 15(7): 2514 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Fishman Infection in Solid-Organ Transplant Recipients N. Engl. J. Med., December 20, 2007; 357(25): 2601 - 2614. [Full Text] [PDF]
|
|
|
|
|
|
E. Gonzalez-Barca, E. Domingo-Domenech, F. J. Capote, J. Gomez-Codina, A. Salar, A. Bailen, J.-M. Ribera, A. Lopez, J. Briones, A. Munoz, et al. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease Haematologica, November 1, 2007; 92(11): 1489 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J Everly, R. D Bloom, D. E Tsai, and J. Trofe Posttransplant Lymphoproliferative Disorder Ann. Pharmacother., November 1, 2007; 41(11): 1850 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M S Dhillon, J K Rai, B K Gunson, S Olliff, and J Olliff Post-transplant lymphoproliferative disease in liver transplantation Br. J. Radiol., May 1, 2007; 80(953): 337 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Mikuls, J. O. Endo, S. E. Puumala, P. A. Aoun, N. A. Black, J. R. O'Dell, J. A. Stoner, E. C. Boilesen, M. A. Bast, D. A. Bergman, et al. Prospective Study of Survival Outcomes in Non-Hodgkin's Lymphoma Patients With Rheumatoid Arthritis J. Clin. Oncol., April 1, 2006; 24(10): 1597 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Ghobrial, T. M. Habermann, M. J. Maurer, S. M. Geyer, K. M. Ristow, T. S. Larson, R. C. Walker, S. M. Ansell, W. R. Macon, G. G. Gores, et al. Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative Disorders J. Clin. Oncol., October 20, 2005; 23(30): 7574 - 7582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Zaltzman, R. Prasad, K. Chun, and S. Jothy Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1748 - 1751. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Schauer, S. Webber, M. Green, and D. Rowe Surface Immunoglobulin-Deficient Epstein-Barr Virus-Infected B Cells in the Peripheral Blood of Pediatric Solid-Organ Transplant Recipients J. Clin. Microbiol., December 1, 2004; 42(12): 5802 - 5810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gupta, B. K. Shenton, M. A. Gok, C. Wilson, J. Asher, G. Hide, B. Wilkins, and D. Talbot Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3186 - 3189. [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Beynet, S. A. Wee, S. S. Horwitz, S. Kohler, S. Horning, R. Hoppe, and Y. H. Kim Clinical and Pathological Features of Posttransplantation Lymphoproliferative Disorders Presenting With Skin Involvement in 4 Patients Arch Dermatol, September 1, 2004; 140(9): 1140 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Duval, M. Raphael, C. Brennetot, H. Poirel, O. Buhard, A. Aubry, A. Martin, A. Krimi, V. Leblond, J. Gabarre, et al. The mutator pathway is a feature of immunodeficiency-related lymphomas PNAS, April 6, 2004; 101(14): 5002 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lee, O. A. Minai, A. C. Mehta, M. M. DeCamp, and S. Murthy Pulmonary Nodules in Lung Transplant Recipients: Etiology and Outcome Chest, January 1, 2004; 125(1): 165 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Siegel, E. Y. Lee, S. C. Sweet, and C. Hildebolt CT of Posttransplantation Lymphoproliferative Disorder in Pediatric Recipients of Lung Allograft Am. J. Roentgenol., October 1, 2003; 181(4): 1125 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W D Bates, D W R Gray, M A Dada, R Chetty, K C Gatter, D R Davies, and P J Morris Lymphoproliferative disorders in Oxford renal transplant recipients J. Clin. Pathol., June 1, 2003; 56(6): 439 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Khanolkar, Z. Fu, L. J. Underwood, K. L. Bondurant, R. Rochford, and M. J. Cannon CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells J. Immunol., March 15, 2003; 170(6): 3187 - 3194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Jenkins, D. T. Rowe, and C. R. Rinaldo Jr. Herpesvirus Infections in Organ Transplant Recipients Clin. Vaccine Immunol., January 1, 2003; 10(1): 1 - 7. [Full Text] [PDF]
|
|
|
|
|
|
V Costes-Martineau, C Delfour, S Obled, L Lamant, G-P Pageaux, P Baldet, P Blanc, and G Delsol Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review J. Clin. Pathol., November 1, 2002; 55(11): 868 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cadranel, M. Wislez, and M. Antoine Primary pulmonary lymphoma Eur. Respir. J., September 1, 2002; 20(3): 750 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Gartner, H. Schafer, K. Marggraff, G. Eisele, M. Schafer, K. Roemer, H.-J. Laws, M. Sester, U. Sester, H. Einsele, et al. Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease J. Clin. Microbiol., February 1, 2002; 40(2): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Sadahira, K Kumori, Y Mikami, T Otsuki, T Manabe, and K Aoyama Post-transplant malignant lymphoma with monoclonal immunoglobulin gene rearrangement and polyclonal Epstein-Barr virus episomes J. Clin. Pathol., November 1, 2001; 54(11): 887 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Cook, R. J. Grostern, N. P. Barney, M. D. Mills, R. Judd, and D. M. Albert Posttransplantation Lymphoproliferative Disorder Initially Seen as Iris Mass and Uveitis Arch Ophthalmol, May 1, 2001; 119(5): 768 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Haddad, S. Paczesny, V. Leblond, J.-M. Seigneurin, M. Stern, A. Achkar, M. Bauwens, V. Delwail, D. Debray, C. Duvoux, et al. Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial Blood, March 15, 2001; 97(6): 1590 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. C. Stevens, E. A. M. Verschuuren, I. Pronk, W. van der Bij, M. C. Harmsen, T. H. The, C. J. L. M. Meijer, A. J. C. van den Brule, and J. M. Middeldorp Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients Blood, March 1, 2001; 97(5): 1165 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Leblond, N. Dhedin, M.-F. M. Bruneel, S. Choquet, O. Hermine, R. Porcher, S. N. Quoc, F. Davi, F. Charlotte, R. Dorent, et al. Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders J. Clin. Oncol., February 1, 2001; 19(3): 772 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Cho, G. N. Holland, B. J. Glasgow, S. J. Isenberg, B. L. George, and S. V. McDiarmid Ocular Involvement in Patients With Posttransplant Lymphoproliferative Disorder Arch Ophthalmol, February 1, 2001; 119(2): 183 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P F Demols, P M Cochaux, T Velu, and L Caspers-Velu Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus Br J Ophthalmol, January 1, 2001; 85(1): 93 - 95. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. J. Swinnen Post-transplant Lymphoproliferative Disorders: Implications for Acquired Immunodeficiency Syndrome-Associated Malignancies J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 38 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Phan, B. P. O'Neill, and P. J. Kurtin Posttransplant primary CNS lymphoma Neuro-oncol, October 1, 2000; 2(4): 229 - 238. [Abstract] [PDF]
|
|
|
|
 |
|
 P. J. Pickhardt, M. J. Siegel, R. J. Hayashi, and M. Kelly Posttransplantation Lymphoproliferative Disorder in Children: Clinical, Histopathologic, and Imaging Features Radiology, October 1, 2000; 217(1): 16 - 25. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Loevner, R. L. Karpati, P. Kumar, D. M. Yousem, W. Hsu, and K. T. Montone Posttransplantation Lymphoproliferative Disorder of the Head and Neck: Imaging Features in Seven Adults Radiology, August 1, 2000; 216(2): 363 - 369. [Abstract] [Full Text]
|
|
|
|
|
|
M. Quaia, P. Zancai, R. Cariati, S. Rizzo, M. Boiocchi, and R. Dolcetti Glucocorticoids promote the proliferation and antagonize the retinoic acid-mediated growth suppression of Epstein-Barr virus-immortalized B lymphocytes Blood, July 15, 2000; 96(2): 711 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. McKean-Cowdin, H. S. Feigelson, R. K. Ross, M. C. Pike, and B. E. Henderson Declining Cancer Rates in the 1990s J. Clin. Oncol., June 11, 2000; 18(11): 2258 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gallagher, J. T. C. Kwan, and P. A. Andrews Post-transplantation lymphoproliferative disorder: an unusual presentation in a patient receiving tacrolimus Nephrol. Dial. Transplant., June 1, 2000; 15(6): 928 - 930. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martin, F. Baran-Marzak, S. El Mansouri, C. Legendre, V. Leblond, F. Charlotte, F. Davi, D. Canioni, and M. Raphael Expression of p16/INK4a in Posttransplantation Lymphoproliferative Disorders Am. J. Pathol., May 1, 2000; 156(5): 1573 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Baldanti, P. Grossi, M. Furione, L. Simoncini, A. Sarasini, P. Comoli, R. Maccario, R. Fiocchi, and G. Gerna High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders J. Clin. Microbiol., February 1, 2000; 38(2): 613 - 619. [Abstract] [Full Text]
|
|
|
|
|
|
A. Gustafsson, V. Levitsky, J.-Z. Zou, T. Frisan, T. Dalianis, P. Ljungman, O. Ringden, J. Winiarski, I. Ernberg, and M. G. Masucci Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells Blood, February 1, 2000; 95(3): 807 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Greiner, J. O. Armitage, and T. G. Gross Atypical Lymphoproliferative Diseases Hematology, January 1, 2000; 2000(1): 133 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Levine, L. Angel, A. Anzueto, I. Susanto, J. I. Peters, E. Y. Sako, and C. L. Bryan A Low Incidence of Posttransplant Lymphoproliferative Disorder in 109 Lung Transplant Recipients Chest, November 1, 1999; 116(5): 1273 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pickhardt and M. J. Siegel Posttransplantation Lymphoproliferative Disorder of the Abdomen: CT Evaluation in 51 Patients Radiology, October 1, 1999; 213(1): 73 - 78. [Abstract] [Full Text]
|
|
|
|
|
|
J. Setsuda, J. Teruya-Feldstein, N. L. Harris, J. A. Ferry, L. Sorbara, G. Gupta, E. S. Jaffe, and G. Tosato Interleukin-18, Interferon-{gamma}, IP-10, and Mig Expression in Epstein-Barr Virus-Induced Infectious Mononucleosis and Posttransplant Lymphoproliferative Disease Am. J. Pathol., July 1, 1999; 155(1): 257 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Limaye, M.-L. Huang, E. E. Atienza, J. M. Ferrenberg, and L. Corey Detection of Epstein-Barr Virus DNA in Sera from Transplant Recipients with Lymphoproliferative Disorders J. Clin. Microbiol., April 1, 1999; 37(4): 1113 - 1116. [Abstract] [Full Text]
|
|
|
|
|
|
K. G. Lucas, R. Filo, D. K. Heilman, C. H. Lee, and D. J. Emanuel Semiquantitative Epstein-Barr Virus Polymerase Chain Reaction Analysis of Peripheral Blood From Organ Transplant Patients and Risk for the Development of Lymphoproliferative Disease Blood, November 15, 1998; 92(10): 3977 - 3979. [Full Text] [PDF]
|
|
|
|
|
|
M. Benkerrou, J.-P. Jais, V. Leblond, A. Durandy, L. Sutton, P. Bordigoni, J. L. Garnier, J. Le Bidois, F. Le Deist, S. Blanche, et al. Anti-B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome Blood, November 1, 1998; 92(9): 3137 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cesarman, A. Chadburn, Y.-F. Liu, A. Migliazza, R. Dalla-Favera, and D. M. Knowles BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome Blood, October 1, 1998; 92(7): 2294 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Murray, C. M. Constandinou, J. Crocker, L. S. Young, and R. F. Ambinder Analysis of Major Histocompatibility Complex Class I, TAP Expression, and LMP2 Epitope Sequence in Epstein-Barr Virus-Positive Hodgkin's Disease Blood, October 1, 1998; 92(7): 2477 - 2483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hale, H. Waldmann, and CAMPATH Users Risks of Developing Epstein-Barr Virus-Related Lymphoproliferative Disorders After T-Cell-Depleted Marrow Transplants Blood, April 15, 1998; 91(8): 3079 - 3083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Ying, P. D. Myerowitz, and W. L. Marsh Jr Posttransplantation Lymphoproliferative Disorder in Cardiac Transplant Allografts Ann. Thorac. Surg., December 1, 1997; 64(6): 1822 - 1824. [Abstract] [Full Text]
|
|
|
|
|
|
O. W. Kamel Lymphomas During Long-term Methotrexate Therapy Arch Dermatol, July 1, 1997; 133(7): 903 - 904. [Abstract] [PDF]
|
|
|
|
|
|
J. M. McNiff, D. Cooper, G. Howe, P. L. Crotty, G. Tallini, J. Crouch, and R. N. Eisen Lymphomatoid Granulomatosis of the Skin and Lung: An Angiocentric T-Cell-Rich B-Cell Lymphoproliferative Disorder Arch Dermatol, December 1, 1996; 132(12): 1464 - 1470. [Abstract] [PDF]
|
|
|
|
|
|
K. B. Miller and F. M. Graeme-Cook Case 19-1996- Multisystem failure in a 33-year-old man after bone marrow transplantation N. Engl. J. Med., June 20, 1996; 334(25): 1655 - 1662. [Full Text] [PDF]
|
|
|
|
|
|
G. Remuzzi and E. Gotti The Girl with the Curl N. Engl. J. Med., October 5, 1995; 333(14): 928 - 931. [Full Text] [PDF]
|
|
|
|
|
|
E. S. Lee, J. Locker, M. Nalesnik, J. Reyes, R. Jaffe, M. Alashari, B. Nour, A. Tzakis, and P. S. Dickman The Association of Epstein-Barr Virus with Smooth-Muscle Tumors Occurring after Organ Transplantation N. Engl. J. Med., January 5, 1995; 332(1): 19 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Ritter and M. R. Wick Posttransplant Lymphoproliferative Disorders: Immunohistologic Differential Diagnosis With Severe Allograft Rejection International Journal of Surgical Pathology, October 1, 1994; 2(2): 105 - 115. [Abstract] [PDF]
|
|
|
|
|
|
E. B. Papadopoulos, M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M. H. Carabasi, H. Castro-Malaspina, B. H. Childs, A. P. Gillio, T. N. Small, et al. Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation N. Engl. J. Med., April 28, 1994; 330(17): 1185 - 1191. [Abstract] [Full Text]
|
|
|
|
|
|
I. J. Spiro, D. W. Yandell, C. Li, S. Saini, J. Ferry, J. Powelson, W. N. Katkov, and A. B. Cosimi Lymphoma of Donor Origin Occurring in the Porta Hepatis of a Transplanted Liver N. Engl. J. Med., July 1, 1993; 329(1): 27 - 29. [Full Text]
|
|
|
|
|
|
O. W. Kamel, M. van de Rijn, L. M. Weiss, G. J. Del Zoppo, P. K. Hench, B. A. Robbins, P. G. Montgomery, R. A. Warnke, and R. F. Dorfman Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and Dermatomyositis N. Engl. J. Med., May 6, 1993; 328(18): 1317 - 1321. [Full Text]
|
|
|
|
|
|
G. Y. Lim, B. Newman, G. Kurland, and S. A. Webber Posttransplantation Lymphoproliferative Disorder: Manifestations in Pediatric Thoracic Organ Recipients Radiology, March 1, 2002; 222(3): 699 - 708. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
